000 01322 a2200337 4500
005 20250517081025.0
264 0 _c20160711
008 201607s 0 0 eng d
022 _a1528-1132
024 7 _a10.1007/s11999-016-4734-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPotter, Benjamin K
245 0 0 _aFrom Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
_h[electronic resource]
260 _bClinical orthopaedics and related research
_cApr 2016
300 _a892-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDenosumab
_xadverse effects
650 0 4 _aDiffusion of Innovation
650 0 4 _aDrug Costs
650 0 4 _aDrug Discovery
_xeconomics
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
_xeconomics
650 0 4 _aResearch Support as Topic
650 0 4 _aTranslational Research, Biomedical
_xeconomics
773 0 _tClinical orthopaedics and related research
_gvol. 474
_gno. 4
_gp. 892-4
856 4 0 _uhttps://doi.org/10.1007/s11999-016-4734-2
_zAvailable from publisher's website
999 _c25729128
_d25729128